Legal & General Group
FLGT icon

Legal & General Group’s Fulgent Genetics FLGT Stock Holding History

Legal & General Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.7K Sell
1,837
-16,970
-90% -$288K ﹤0.01% 2871
2026
Q1 		$299K Sell
18,807
-2,149
-10% -$46.6K ﹤0.01% 2471
2025
Q4 		$551K Sell
20,956
-69
-0.3% -$1.79K ﹤0.01% 2400
2025
Q3 		$475K Hold
21,025
– – ﹤0.01% 2458
2025
Q2 		$418K Buy
21,025
+2,599
+14% +$50.7K ﹤0.01% 2490
2025
Q1 		$311K Sell
18,426
-79,651
-81% -$1.36M ﹤0.01% 2536
2024
Q4 		$1.81M Buy
98,077
+6,651
+7% +$130K ﹤0.01% 2011
2024
Q3 		$1.99M Sell
91,426
-6,196
-6% -$139K ﹤0.01% 1971
2024
Q2 		$1.92M Sell
97,622
-9,588
-9% -$200K ﹤0.01% 1962
2024
Q1 		$2.33M Buy
107,210
+6,896
+7% +$171K ﹤0.01% 1878
2023
Q4 		$2.9M Sell
100,314
-13,543
-12% -$362K ﹤0.01% 1763
2023
Q3 		$3.04M Buy
113,857
+9,317
+9% +$318K ﹤0.01% 1700
2023
Q2 		$3.87M Sell
104,540
-5,761
-5% -$201K ﹤0.01% 1601
2023
Q1 		$3.44M Buy
110,301
+2,800
+3% +$90.1K ﹤0.01% 1614
2022
Q4 		$3.2M Buy
107,501
+5,395
+5% +$193K ﹤0.01% 1648
2022
Q3 		$3.89M Buy
102,106
+9,684
+10% +$485K ﹤0.01% 1492
2022
Q2 		$5.04M Sell
92,422
-1,413
-2% -$77.7K ﹤0.01% 1411
2022
Q1 		$5.86M Buy
93,835
+5,364
+6% +$353K ﹤0.01% 1433
2021
Q4 		$8.9M Buy
88,471
+1,146
+1% +$101K ﹤0.01% 1272
2021
Q3 		$7.86M Buy
87,325
+11,620
+15% +$1.06M ﹤0.01% 1302
2021
Q2 		$6.98M Sell
75,705
-3,973
-5% -$317K ﹤0.01% 1363
2021
Q1 		$7.7M Buy
79,678
+12,303
+18% +$1.27M ﹤0.01% 1365
2020
Q4 		$3.51M Buy
67,375
+11,883
+21% +$497K ﹤0.01% 1655
2020
Q3 		$2.22M Buy
55,492
+53,896
+3,377% +$1.69M ﹤0.01% 1722
2020
Q2 		$26K Buy
+1,596
New +$24.4K ﹤0.01% 2951

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Legal & General Group's FLGT Position: Q2 2026 in Review

Legal & General Group reduced its Fulgent Genetics (FLGT) stake by 90% in Q2 2026, selling an estimated $288K and leaving 1,837 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2871.

Legal & General Group first reported a position in FLGT in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.9M in Q4 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Legal & General Group held 1,837 shares of Fulgent Genetics worth $37.7K as of Q2 2026.
  • Legal & General Group sold 16,970 Fulgent Genetics shares in Q2 2026, an estimated $288K.
  • Fulgent Genetics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2871 holding.
  • Legal & General Group first reported a position in Fulgent Genetics in Q2 2020 and has held it in 25 quarters since.
  • Legal & General Group's Fulgent Genetics position peaked at $8.9M in Q4 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.